Phoenix, AZ11 Active Studies

Migraine Clinical Trials in Phoenix, AZ

Find 11 actively recruiting migraine clinical trials in Phoenix, AZ. Connect with local research sites and explore new treatment options.

11
Active Trials
5
Sponsors
9,306
Enrolling

Recruiting Migraine Studies in Phoenix

RecruitingPhoenix, AZNCT04396236

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits....

1,633 participants
Eli Lilly and Company
View Study Details
RecruitingPhoenix, AZNCT06972056

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive me...

1,335 participants
Mayo Clinic
View Study Details
RecruitingPhoenix, AZNCT05125302

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Mig...

1,059 participants
AbbVie
View Study Details
RecruitingPhoenix, AZNCT04396574

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will la...

1,000 participants
Eli Lilly and Company
View Study Details
RecruitingPhoenix, AZNCT07018700

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

In this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine d...

990 participants
Merz Therapeutics GmbH
View Study Details
RecruitingPhoenix, AZNCT07018713

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

In this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine da...

780 participants
Merz Therapeutics GmbH
View Study Details
RecruitingPhoenix, AZNCT06047444

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine. A migraine is a headache with severe thr...

720 participants
Ipsen
View Study Details
RecruitingPhoenix, AZNCT06047457

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic migraine. A migraine is a headache with severe th...

714 participants
Ipsen
View Study Details
RecruitingPhoenix, AZNCT06417775

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, o...

450 participants
AbbVie
View Study Details
RecruitingPhoenix, AZNCT03432286

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is t...

325 participants
Eli Lilly and Company
View Study Details
RecruitingPhoenix, AZNCT04616326

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is t...

300 participants
Eli Lilly and Company
View Study Details

About Migraine Clinical Trials in Phoenix

Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.

There are currently 11 migraine clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 9,306 participants. Research is being sponsored by Eli Lilly and Company, Mayo Clinic, AbbVie and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Migraine Clinical Trials in Phoenix — FAQ

Are there migraine clinical trials in Phoenix?

Yes, there are 11 migraine clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What migraine treatments are being tested?

The 11 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.

Data updated March 2, 2026 from ClinicalTrials.gov